The information below is intended as a reference only, and should not be taken as medical advice. If you have questions about your medications, consult your pharmacist, doctor, nurse, or other healthcare professional.
Resources
NSW Therapeutic Advisory Group Inc.
- Neurological Drugs – Anticholinergic drugs for Parkinsonism [PDF]
- Genitourinary Drugs – Anticholinergic drugs for Urinary Incontinence (Antimuscarinics) [PDF]
References & Relevant Literature
- Boustani MA, Campbell NL, Munger S, Maidment I, Fox GC. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311-20.
- Richardson Kathryn, Fox Chris, Maidment Ian, Steel Nicholas, Loke Yoon K, Arthur Antony et al. Anticholinergic drugs and risk of dementia: case-control study BMJ 2018.
- Common anticholinergic drugs like Benadryl linked to increased dementia risk. Harvard Health Publishing.
- Patient Handout First-generation antihistamines. Bruyere Research Institute at deprescribing.org.
- Jama: Anticholinergic Drug Exposure and the Risk of Dementia A Nested Case-Control Study.
- Simon FER and Simons KJ. (2008). H1 Antihistamines. Current Status and Future Direction. Review article. World Allergy Organ J. 1(9): 145-155.
- Slavin RG. (2009). Treating rhinitis in the older population: special considerations. Allergy, Asthma, and Clin Immunol. Review. 5(1):9.